Evidence map›Paper›PMID 41311426›Full record

ArticleRSC chemical biology2026

Dual spatio-functional control of a fission yeast-based bioprocessor upon chemical induction.

Stavroula Melina Sakellakou, Valérie Migeot, Laure-Elie Carloni, Elisa Martino, André Oliveira Sequeira, Terézia Morávková, Lorenzo Riccio, Sorin Melinte, Laura Maggini, Damien Hermand and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stavroula Melina SakellakouInstitute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38 1090 Vienna Austria Laura.Maggini@univie.ac.at Davide.Bonifazi@univie.ac.at.
Valérie MigeotURPHYM-GEMO, The University of Namur, rue de Bruxelles, 61 Namur 5000 Belgium Damien.Hermand@crick.ac.uk.
Laure-Elie CarloniDepartment of Chemistry, The University of Namur, rue de Bruxelles, 61 Namur 5000 Belgium.
Elisa MartinoSchool of Chemistry, Cardiff University Park Place CF10 3AT Cardiff UK.ORCID https://orcid.org/0000-0002-9564-1542
André Oliveira SequeiraInstitute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38 1090 Vienna Austria Laura.Maggini@univie.ac.at Davide.Bonifazi@univie.ac.at.
Terézia MorávkováInstitute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38 1090 Vienna Austria Laura.Maggini@univie.ac.at Davide.Bonifazi@univie.ac.at.ORCID https://orcid.org/0000-0003-0312-5653
Lorenzo RiccioInstitute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38 1090 Vienna Austria Laura.Maggini@univie.ac.at Davide.Bonifazi@univie.ac.at.ORCID https://orcid.org/0009-0004-6578-9265
Sorin MelinteInstitute of Information and Communication Technologies, Electronics and Applied Mathematics, Université catholique de Louvain 1348 Louvain-la-Neuve Belgium.ORCID https://orcid.org/0000-0003-2176-554X
Laura MagginiInstitute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38 1090 Vienna Austria Laura.Maggini@univie.ac.at Davide.Bonifazi@univie.ac.at.ORCID https://orcid.org/0000-0001-9434-9470
Damien HermandURPHYM-GEMO, The University of Namur, rue de Bruxelles, 61 Namur 5000 Belgium Damien.Hermand@crick.ac.uk.
Davide BonifaziInstitute of Organic Chemistry, Faculty of Chemistry, University of Vienna, Währinger Straße 38 1090 Vienna Austria Laura.Maggini@univie.ac.at Davide.Bonifazi@univie.ac.at.ORCID https://orcid.org/0000-0001-5717-0121

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next-generation therapies are advancing beyond small molecules and proteins toward engineered living microorganisms that interact symbiotically with their host and respond to signals precisely when and where needed. Despite progress in the field, engineering cells to both produce biopharmaceuticals and achieve site-specific recruitment remains a challenge. In this work, we genetically engineered the mating pathway of

Identifiers

PMID41311426
PMCPMC12650765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.